# Combination Chemotherapy Plus Peripheral Stem Cell Transplantation With or Without Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma

> **NCT00005589** · PHASE3 · COMPLETED · sponsor: **EBMT Solid Tumors Working Party** · enrollment: 460 (estimated)

## Conditions studied

- Lymphoma

## Interventions

- **BIOLOGICAL:** filgrastim
- **BIOLOGICAL:** rituximab
- **DRUG:** carmustine
- **DRUG:** cyclophosphamide
- **DRUG:** cytarabine
- **DRUG:** etoposide
- **DRUG:** melphalan
- **PROCEDURE:** bone marrow ablation with stem cell support
- **PROCEDURE:** peripheral blood stem cell transplantation

## Key facts

- **NCT ID:** NCT00005589
- **Lead sponsor:** EBMT Solid Tumors Working Party
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-10
- **Primary completion:** —
- **Final completion:** 2013-04
- **Target enrollment:** 460 (ESTIMATED)
- **Last updated:** 2013-09-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00005589

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00005589, "Combination Chemotherapy Plus Peripheral Stem Cell Transplantation With or Without Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00005589. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*